Sonnie Kim serves as Vice President of Medical & Scientific Affairs at Braeburn Pharmaceuticals. She has nearly 20 years of leadership experience driving medical affairs and scientific programs across a range of therapeutic areas, including pain management, addiction medicine and cardiovascular disease. At Braeburn, Dr. Kim oversees clinical trial design and execution for products in development and leads all medical affairs activities. Prior to joining Braeburn Pharmaceuticals, Dr. Kim was with Otsuka America Pharmaceutical, Inc., as a Director of Medical Affairs/Hospital Medicine and integral in the pre- and post-launch medical affairs activities and programs for SAMSCA, including development of phase 4 program, building health economic models and forming Medical Science Liaison team. Dr. Kim has previously been with WebMD, LLC, where she developed and deployed analytical tools to shape the strategy of WebMD’s Medscape Education program. Dr. Kim’s previous experience also includes roles as Vice President and Board member of Columbia Medcom Group, Inc., and it’s subsidiary, Medicallaince, Inc., and a teaching and clinical role at the University of Maryland School of Pharmacy. Dr. Kim holds a Doctorate of Pharmacy from the University of Maryland School of Pharmacy.